Qlibrium
Qlibrium is revolutionizing on‑body delivery systems by starting with the patient experience. Qlibrium innovates on-body delivery systems (OBDS) for both patients and pharmaceutical companies with the first electrochemical and microfluidic technology platform that is ultra‑slim, simple to use, and designed to complement the pharmaceutical pipelines of today and tomorrow.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Nationally (across the country)
- Year Founded:
- 2014
About Us
Our Mission. Qlibrium is committed to helping patients live life to the fullest by developing and innovating discreet and flexible drug delivery solutions.
Our Aim. Qlibrium is developing a highly flexible platform for delivering injectable drugs into subcutaneous tissue with a wearable on-body delivery system that brings dramatic improvements over existing devices to both users and to pharmaceutical companies.
Who is Qlibrium
Qlibrium, formerly known as Cam Med, began with a simple question: Why can’t a pump for injectable drugs work like an extension of the body? For patients with chronic conditions such as diabetes, Parkinson’s disease, hormone deficiencies, and blood disorders, as well as other conditions that require frequent subcutaneous injections of drugs, a better wearable experience translates into improved compliance and outcomes.
Qlibrium has been working to bring our vision of marked simplicity to reality with development of the patent-protected QLib platform for pre-filled subcutaneous delivery of drugs and QForma for diabetes patients.
Our innovative work has been recognized with prizes from MassChallenge, the Centre for Advancement of Science in Space, the New England Pediatric Device Consortium, the Massachusetts Medical Device Development Center, and we are a member of JLABS, part of Johnson & Johnson Innovation.
Today, we are working with pharmaceutical partners to deliver a better experience to patients because patient acceptance is key to compliance.
Qlibrium’s innovations put the patient exper...
Qlibrium’s innovations put the patient experience front and center with an on-body delivery system that is over 40% thinner than the leading wearable at just 8 millimeters thin. It applies with a simple click, and meets patients’ need for ease of use and livability.
See how the Qlibrium Technology empowers diabetes patients with the Qforma Insulin PumpThe Qlibrium platform also meets the needs of our pharmaceutical partners by seamlessly integrating into standard fill-finish and sterilization processes with a slim, wearable form factor that creates user acceptance and improves compliance.
Explore the Qlib™ On-Body Delivery System (OBDS) Platform, Designed to Work With Existing Fill-Finish and Sterilization Processes.